Affiliate Disclosure
This article contains affiliate links. If you purchase through these links, we may earn a commission at no additional cost to you. This does not influence our evaluations or rankings.
HBOT for Lyme disease targets the oxygen-sensitive Borrelia burgdorferi spirochete with pressurized oxygen delivery. In vitro studies show Borrelia has limited oxygen defense mechanisms, and preliminary clinical reports document symptom improvement in patients with persistent Lyme who failed antibiotic therapy. No large RCTs exist yet. This guide covers the biological rationale, clinical evidence, typical protocols, and costs. It is one of several HBOT research across chronic conditions that researchers are actively investigating.
Editor’s Note: HBOT for Lyme disease is a controversial topic. The mainstream medical community does not endorse it, but a growing number of Lyme-literate physicians use it as part of comprehensive treatment protocols. We present both perspectives and the evidence behind each.
Table of Contents
From the author
My own health issues started with mold exposure that triggered a system-wide inflammatory cascade. The overlap between mold illness and chronic Lyme in terms of symptoms, immune dysregulation, and treatment approaches is something I’ve navigated personally. I write about HBOT for Lyme with the understanding that these patients are often desperate for something that works and that honest reporting on the evidence matters more here than almost anywhere else.
How Does HBOT Work for Lyme Disease?
When you use a hyperbaric chamber for Lyme disease, you breathe 100% oxygen while sitting in a chamber with higher air pressure than normal, usually 1.5 to 3 times the regular pressure. This creates an oxygen-rich environment that can affect the bacteria in several ways.
Research has shown that high oxygen levels can stress and damage Borrelia burgdorferi bacteria.2 The treatment works through several mechanisms:
Fighting Bacteria Directly: The extra oxygen creates conditions that are harmful to the bacteria that causes Lyme disease.
Helping Your Immune System: More oxygen in your tissues helps your body’s natural defenses work better against the infection.
Making Antibiotics Work Better: HBOT can help antibiotics reach infected areas more easily and work more effectively.
HBOT is not FDA-approved for Lyme disease, and no randomized controlled trials have been conducted. The only laboratory study suggesting HBOT may inhibit Borrelia growth was published in 2000 and has never been replicated.2
How Does HBOT Work at the Cellular Level?
Hyperbaric oxygen therapy means breathing 100% oxygen in a special chamber where the air pressure is higher than normal. This allows your lungs to take in much more oxygen than usual. The extra oxygen gets dissolved into your blood and reaches all parts of your body, even areas with poor blood flow due to infection.
The high-pressure oxygen environment creates reactive oxygen species, special molecules that can damage the bacteria’s cell walls and interfere with important processes the bacteria need to survive. Borrelia burgdorferi bacteria need small amounts of oxygen to survive, but they have limited defenses against too much oxygen. This makes oxygen therapy theoretically effective against these bacteria, though clinical evidence remains very limited.
What Does the Research Say?
The research supporting hyperbaric chamber treatment for Lyme disease is still very limited. The clinical evidence consists of a single published case report and one preliminary in-vitro study from 2000 that has never been replicated.1,2
The case report documented:
- Symptom relief: A single patient with chronic Lyme disease experienced significant symptom relief after 30 HBOT sessions (90 min each): joint pain, eye twitch, sleep disorder, numbness, and short-term memory problems all resolved.1
- Limits of the data: No randomized controlled trials exist. Patient survey data shows only 22% self-reported effectiveness.3
What Does the Research Say?
HBOT has theoretical appeal for neurological Lyme disease, when the infection affects the brain and nervous system. The blood-brain barrier can make it hard for antibiotics to reach brain tissues, but HBOT’s additional dissolved oxygen may reach these areas.
To be clear: the research base is a single case report and one unconfirmed lab study. This is not a foundation for clinical recommendations. More research is genuinely needed before HBOT can be endorsed for Lyme disease.
What Does the HBOT Protocol Look Like?
If you’re considering a hyperbaric chamber for Lyme disease, understanding the typical treatment protocol helps set realistic expectations. See also: session frequency.
Standard Treatment Parameters:
- Pressure: 2.0 to 2.5 ATA (atmospheres absolute)
- Duration: 60 to 90 minutes per session
- Frequency: 5 days per week for 4 to 8 weeks
- Total Sessions: 20 to 40 sessions typically
During each session, you’ll lie comfortably in the pressurized chamber while breathing 100% oxygen. Many patients use this time for relaxation, reading, or listening to music. The chamber gradually pressurizes over 10 to 15 minutes, maintains treatment pressure for the prescribed duration, then slowly depressurizes.
What Does the HBOT Protocol Look Like?
Treatment plans vary based on several factors:
- Disease Stage: Acute vs. chronic Lyme disease
- Symptom Severity: Neurological involvement may require longer protocols
- Patient Response: Some individuals need extended treatment courses
- Concurrent Treatments: Integration with antibiotic therapy
Your hyperbaric physician will develop a personalized protocol considering your specific situation, medical history, and treatment goals.
How Does HBOT Compare to Other Treatments?
While antibiotics remain the standard first-line treatment for Lyme disease, some practitioners explore HBOT as an adjunct in cases where standard treatments have not achieved adequate results.
Antibiotic Treatment Challenges:
- Hard for antibiotics to reach all infected areas
- Bacteria can form protective biofilms
- Bacteria can survive in low-oxygen areas
- Some bacteria may become resistant to antibiotics
Theoretical HBOT Benefits:
- Direct oxygen exposure may harm anaerobic or microaerophilic bacteria
- May help antibiotics reach and work in more areas
- Boosts immune system function
- Reduces inflammation
How Does HBOT Compare to Other Treatments?
Rather than choosing one treatment over another, some Lyme-literate physicians use both together. This approach lacks robust clinical trial evidence, and patients should weigh the cost and time commitment carefully given the limited data.
Who Is a Good Candidate for HBOT?
Not all Lyme disease patients are ideal candidates for hyperbaric oxygen therapy. Based on limited available data, some practitioners suggest the following groups:
Possible Candidates Include:
- Patients with long-term Lyme disease that hasn’t responded to antibiotics
- People with persistent neurological symptoms from Lyme
- Those with ongoing fatigue and joint pain after antibiotic treatment
- Patients with confirmed Lyme disease who have exhausted standard options
Approximately 20% of Lyme patients develop chronic symptoms known as post-treatment Lyme disease syndrome. Standard antibiotics are the first line; HBOT remains investigational for this group with only a single case report and unconfirmed lab data.3
Long-term vs. Recent Lyme Disease Cases
People with long-term (chronic) Lyme disease are those most likely to seek HBOT, as they typically have:
- Symptoms that continue after antibiotic treatment
- Multiple body systems affected
- Bacterial populations possibly protected by biofilms
- Weakened immune function
Neurological Lyme Disease
When Lyme disease affects the brain and nervous system, the blood-brain barrier can make antibiotic penetration difficult. HBOT theoretically improves oxygenation in these areas, though clinical evidence specific to neurological Lyme is limited to anecdotal reports.
What Are the Side Effects and Risks?
Hyperbaric chamber therapy for Lyme disease is generally safe when administered by qualified professionals, but understanding potential risks ensures informed decision-making.
Common Side Effects:
- Ear pressure or discomfort
- Temporary vision changes
- Fatigue after initial sessions
- Sinus congestion
Rare but Serious Risks:
- Pneumothorax (collapsed lung)
- Oxygen toxicity
- Fire hazard (due to high oxygen concentration)
How Do You Find the Right HBOT Clinic?
Choosing the right facility for your hyperbaric chamber Lyme disease treatment significantly impacts your experience and outcomes. Look for centers that understand Lyme disease complexities and have experience treating chronic infections.
Key Selection Criteria:
- Board-certified hyperbaric physicians
- Lyme disease treatment experience
- Proper facility accreditation
- Comprehensive pre-treatment evaluation
- Integration with infectious disease specialists
Conclusion
HBOT for Lyme disease is genuinely experimental. The evidence base is a single case report and one unconfirmed lab study from over two decades ago. Patient survey data shows low self-reported effectiveness. These facts don’t rule out individual benefit for some people, but they do mean entering this treatment with honest expectations rather than optimistic marketing claims.
If you’re considering it, work with qualified healthcare providers who understand both Lyme disease and hyperbaric medicine. Keep standard treatments in place. And be realistic: HBOT is not a proven cure for Lyme disease.
Who Should Not Try HBOT
HBOT is generally safe when administered by trained professionals, but it is not appropriate for everyone. Discuss your full medical history with your provider before starting treatment.
Absolute Contraindications
HBOT should not be used if you have:
- Untreated pneumothorax (collapsed lung) – pressure changes can worsen this condition and become life-threatening
- Certain chemotherapy drugs – bleomycin, cisplatin, doxorubicin, and disulfiram may interact dangerously with high-oxygen environments
Relative Contraindications
Your provider may need to take extra precautions or postpone treatment if you have:
- Upper respiratory infection or sinus congestion – difficulty equalizing pressure can cause ear or sinus barotrauma
- Seizure disorder – high-pressure oxygen can lower seizure threshold in susceptible individuals
- Chronic obstructive pulmonary disease (COPD) – altered breathing drive may require modified protocols
- High fever – increases the risk of oxygen toxicity
- History of ear surgery or chronic ear problems – pressure equalization may be difficult or risky
- Claustrophobia – may require sedation or use of a multiplace chamber instead
- Pregnancy – insufficient safety data exists for routine use during pregnancy
Talk to Your Doctor First
Even if you do not have the conditions listed above, always consult your physician before starting HBOT, especially if you take insulin (blood sugar may drop during treatment), have a pacemaker or implanted device, or are currently taking any medications. For a full overview of HBOT side effects and risks, see our detailed guide.
Related Guides
- Best Home Hyperbaric Chambers – Options for long-term home Lyme treatment
- HBOT Treatment Cost – Session pricing for ongoing Lyme protocols
- HBOT for Wound Healing – Related HBOT application
- HBOT for Long COVID – Similar chronic condition treatment
- HBOT for Athletes – Recovery and performance applications
References
- Huang CY, et al. Hyperbaric oxygen therapy as an effective adjunctive treatment for chronic Lyme disease. J Chin Med Assoc. 2014;77(5):269-271. DOI: 10.1016/j.jcma.2014.02.001
- Fife WP, et al. Effect of hyperbaric oxygen on Borrelia burgdorferi in vitro. Texas A&M University Health Science Center, 1998. (In-vitro/mouse model, unreplicated.)
- LymeDisease.org. MyLyme Data Chart Book, 2019. Patient-reported HBOT outcomes (N=347).
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
Why Trust Our Evaluations
Our rankings are based on hands-on testing, published clinical data, and verified manufacturer specifications. We apply the same criteria to every product regardless of affiliate status. Editorial Process · Evaluation Methodology
